Correlation Between Adamis Pharma and Organogenesis Holdings

Can any of the company-specific risk be diversified away by investing in both Adamis Pharma and Organogenesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adamis Pharma and Organogenesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Adamis Pharma and Organogenesis Holdings, you can compare the effects of market volatilities on Adamis Pharma and Organogenesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adamis Pharma with a short position of Organogenesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adamis Pharma and Organogenesis Holdings.

Diversification Opportunities for Adamis Pharma and Organogenesis Holdings

0.0

Correlation Coefficient

Adamis Pharma  Organogenesis Holdings

Pay attention - limited upside

The 3 months correlation between Adamis and Organogenesis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Adamis Pharma and Organogenesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organogenesis Holdings and Adamis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adamis Pharma are associated (or correlated) with Organogenesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organogenesis Holdings has no effect on the direction of Adamis Pharma i.e., Adamis Pharma and Organogenesis Holdings go up and down completely randomly.

Pair Corralation between Adamis Pharma and Organogenesis Holdings

If you would invest  386.00  in Organogenesis Holdings on December 2, 2024 and sell it today you would earn a total of  235.00  from holding Organogenesis Holdings or generate 60.88% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Adamis Pharma  vs.  Organogenesis Holdings

Adamis Pharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Adamis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Adamis Pharma is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Organogenesis Holdings

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Organogenesis Holdings are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent technical and fundamental indicators, Organogenesis Holdings displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Adamis Pharma and Organogenesis Holdings

The main advantage of trading using opposite Adamis Pharma and Organogenesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adamis Pharma position performs unexpectedly, Organogenesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will offset losses from the drop in Organogenesis Holdings' long position.

The idea behind Adamis Pharma and Organogenesis Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.